Journals / Turkish Journal of Chemistry / 2005 / Cilt: 29 - Sayı: 4

O-Galloyl Flavonoids from Geranium pyrenaicum and Their in vitro Antileishmanial Activity

Pages
437–443
Publication Date
2005-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Compounds 1-7 were evaluated for antileishmanial activity against a panel of Leishmania species (L. major, L. donovani and L. amazonensis), indicating appreciable in vitro activities (IC50 4-27 nM) when compared with Pentostam (IC50 10-11 nM).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:From the aerial parts of Geranium pyrenaicum Burm., a new flavonol glycoside, kaempferol 3-O-(2'',3''-di-O-galloyl)-{\ss}-D-glucopyranoside (7), along with 6 known related glycosides [kaempferol 3-O-b-D-glucopyranoside (1), quercetin 3-O-b-D-glucopyranoside (2), quercetin 3-O-b-D-galactopyranoside (3), kaempferol 3-O-(2''-O-galloyl)-b-D-glucopyranoside (4), quercetin 3-O-(2''-O-galloyl)-b-D-glucopyranoside (5) and quercetin 3-O-(2'',3''-di-O-galloyl)-{\ss}-D-glucopyranoside (6)] and the ellagitannins corilagin (8) and tellimagrandin I (9) were isolated.
📊
Key Findings & Data:Their structures were established from spectroscopic studies (UV, FAB-MS, 1H and 13C-NMR, 1H-1H COSY, HETCOR, HMBC).
💡
Conclusion & Impact:Compounds 1-7 were evaluated for antileishmanial activity against a panel of Leishmania species (L. major, L. donovani and L. amazonensis), indicating appreciable in vitro activities (IC50 4-27 nM) when compared with Pentostam (IC50 10-11 nM).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Geranium pyrenaicum · Geraniaceae · Flavonoids

Abstract

From the aerial parts of Geranium pyrenaicum Burm., a new flavonol glycoside, kaempferol 3-O-(2'',3''-di-O-galloyl)-{\ss}-D-glucopyranoside (7), along with 6 known related glycosides [kaempferol 3-O-b-D-glucopyranoside (1), quercetin 3-O-b-D-glucopyranoside (2), quercetin 3-O-b-D-galactopyranoside (3), kaempferol 3-O-(2''-O-galloyl)-b-D-glucopyranoside (4), quercetin 3-O-(2''-O-galloyl)-b-D-glucopyranoside (5) and quercetin 3-O-(2'',3''-di-O-galloyl)-{\ss}-D-glucopyranoside (6)] and the ellagitannins corilagin (8) and tellimagrandin I (9) were isolated. Their structures were established from spectroscopic studies (UV, FAB-MS, 1H and 13C-NMR, 1H-1H COSY, HETCOR, HMBC). Compounds 1-7 were evaluated for antileishmanial activity against a panel of Leishmania species (L. major, L. donovani and L. amazonensis), indicating appreciable in vitro activities (IC50 4-27 nM) when compared with Pentostam (IC50 10-11 nM).

Özet

From the aerial parts of Geranium pyrenaicum Burm., a new flavonol glycoside, kaempferol 3-O-(2'',3''-di-O-galloyl)-{\ss}-D-glucopyranoside (7), along with 6 known related glycosides [kaempferol 3-O-b-D-glucopyranoside (1), quercetin 3-O-b-D-glucopyranoside (2), quercetin 3-O-b-D-galactopyranoside (3), kaempferol 3-O-(2''-O-galloyl)-b-D-glucopyranoside (4), quercetin 3-O-(2''-O-galloyl)-b-D-glucopyranoside (5) and quercetin 3-O-(2'',3''-di-O-galloyl)-{\ss}-D-glucopyranoside (6)] and the ellagitannins corilagin (8) and tellimagrandin I (9) were isolated. Their structures were established from spectroscopic studies (UV, FAB-MS, 1H and 13C-NMR, 1H-1H COSY, HETCOR, HMBC). Compounds 1-7 were evaluated for antileishmanial activity against a panel of Leishmania species (L. major, L. donovani and L. amazonensis), indicating appreciable in vitro activities (IC50 4-27 nM) when compared with Pentostam (IC50 10-11 nM).

🔖

Cite This Article

ERCİL, D., KALOGA, M., RADTKE, O. A., SAKAR, M. K., KIDERLEN, A. F., KOLODZIEJ, H. (2005). O-Galloyl Flavonoids from Geranium pyrenaicum and Their in vitro Antileishmanial Activity. Turkish Journal of Chemistry, Cilt: 29 - Sayı: 4, 437–443. https://ajindex.com/articles/382195

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. R. Hegnauer, “Chemotaxonomie der Pflanzen” Vol. VIII, Birkhauser Verlag, Basel, Berlin, 511-516. 1989. T. Baytop, “Therapy with medicinal plants in Turkey (Past and Present)” 2ndNobel Tıp Kitabevleri Ltd., ˙Istanbul, 1999. P.H. Davis, “Geranium” in Flora of Turkey and the East Aegean Islands vol. 2, ed. P.H. Davis, pp. 441-474,
  2. University Press, Edinburgh, 1966. H. Ay¸ci¸cek and M. Tany¨uksel, T¨urk Hij. Den. Biyol. Derg. 54, 35-39 (1997). U.Z. Ok, ˙I.C. Balcıo˘glu, A. Taylan ¨Ozkan, S. ¨Ozensoy and Y. ¨Ozbel, Acta Trop. 84, 43-48 (2002). ¨ H. Kolodziej, O. Kayser, A.F. Kiderlen, H. Ito, T. Hatano, T. Yoshida and L.Y. Foo, Biol. Pharm. Bull. 24, 1021 (2001).
  3. O.A. Radtke, L.Y. Foo, Y. Lu, A.F. Kiderlen and H. Kolodziej, Z. Naturforsch. 58c, 395-400 (2003).
  4. K.P. Latte and H. Kolodziej, Phytochemistry 54, 701-708 (2000).
  5. C.K. Wilkins and B.A. Bohm, Phytochemistry 15, 211-214 (1976).
  6. S. Funayama and H. Hikino, Chem. Pharm. Bull. 27, 2865-2868 (1979).
  7. K.R. Markham, B. Ternai, R. Stanley, H. Geiger and T.J. Mabry, Tetrahedron 34, 1389-1397 (1978).
  8. T. Isobe, N. Ito and Y. Noda, Phytochemistry 19, 1877 (1980).
  9. T. Isobe, T. Fukushige and Y. Noda, Chem. Lett. 27-30 (1979).
  10. Y. Amakura, K. Kawada, T. Hatano, I. Agata, T. Sugaya, S. Nishibe, T. Okuda and T. Yoshida, Can. J. Chem. 75, 727-733 (1997).
  11. H.Y. Kim, B.H. Moon, H.J. Lee and D.H. Choi, J. Ethnopharmacol. 93, 227-230 (2004).
  12. B. Beutler and A. Cerami, Annu. Rev. Immunol. 7, 625-655 (1989).
  13. A. Billiau, Adv. Immunol. 62, 61-130 (1996). J. Theza, “The Cytokine Network and Immune Functions”, Oxford University Press,
  14. Inc., New York, 1999.
  15. M. Helle, L. Boeije and L.A. Aarden, Eur. J. Immunol. 18, 1535-1540 (1988).
  16. M. Liu, P. Wilairat, S.L. Croft, A.L. Tan and M. Go, Bioorg. Med. Chem. 11, 2729-2738 (2003).
  17. O. Kayser, A.F. Kiderlen, U. Folkens and H. Kolodziej, Planta Med. 65, 316-319 (1999).
  18. H. Kolodziej and A.F. Kiderlen, Phytochemistry (in press) (2005).